Solos Endoscopy Inc. passed muster during an inspection by the federal Food and Drug administration, earning a “No Action Indicated” mark from the agency.
The Boston-based device maker, which manufactures endoscopic instrumentation and medical imaging products, said the FDA found no problems during its Level II baseline inspection.